Ding Yudan, Wang Li, Chen Jindong, Zhao Jingping, Guo Wenbin
Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, China.
National Clinical Research Center on Mental Disorders, Changsha, China.
Front Psychol. 2020 Apr 23;11:769. doi: 10.3389/fpsyg.2020.00769. eCollection 2020.
Chinese Taoist cognitive therapy (CTCT), a culture-oriented psychological therapy for Chinese mental well-being, has been proposed for decades. However, the evidence for its effects is unclear. This study aimed to systematically assess the effect of this therapy on symptoms of depression and anxiety in Chinese adults. Relevant studies were searched from major electronic databases through November 2018 without language limits. Several search terms used include "anxiety" OR "depression" AND "Taoism" OR "Daoism" OR "Chinese Taoist Cognitive Therapy." A total of 11 clinical trials focusing on CTCT were included in this meta-analysis. Random-effects meta-analytical models were conducted. Heterogeneity and publication bias were also explored. Eight clinical trials for 580 subjects were included. The majority of these studies explored samples with depressive symptoms. Overall, CTCT significantly reduced depressive symptoms with a small positive effect (SMD = 0.16, 95% CI: -0.36-0.68). Medium-to-large effect sizes were observed across individuals with clinical or non-clinical depression and chronic physical diseases (SMD = 0.70, 95%CI: 0.27-1.13 and SMD = 0.72, 95%CI: 0.09-1.35, respectively). However, the effectiveness for anxiety symptoms remains debatable. Our findings hold promise that CTCT can help reduce depressive symptoms in Chinese adults, including patients with chronic physical diseases and clinical or non-clinical depression. Our findings may be generalized to Chinese communities in other countries.
中国道家认知疗法（CTCT）是一种旨在促进中国人心理健康的、以文化为导向的心理治疗方法，已提出数十年。然而，其疗效证据尚不清楚。本研究旨在系统评估该疗法对中国成年人抑郁和焦虑症状的影响。通过检索主要电子数据库，搜索截至2018年11月的相关研究，无语言限制。使用的检索词包括“焦虑”或“抑郁”以及“道教”或“道家”或“中国道家认知疗法”。本荟萃分析共纳入11项聚焦于CTCT的临床试验。采用随机效应荟萃分析模型，并探讨异质性和发表偏倚。纳入了针对580名受试者的8项临床试验。这些研究大多探讨了有抑郁症状的样本。总体而言，CTCT显著减轻了抑郁症状，有小的积极效应（标准化均数差=0.16，95%置信区间：-0.36至0.68）。在患有临床或非临床抑郁症以及慢性躯体疾病的个体中观察到中到较大的效应量（标准化均数差分别为0.70，95%置信区间：0.27至1.13和0.72，95%置信区间：0.09至1.35）。然而，其对焦虑症状的有效性仍存在争议。我们的研究结果表明，CTCT有望帮助减轻中国成年人的抑郁症状，包括患有慢性躯体疾病以及临床或非临床抑郁症的患者。我们的研究结果可能推广至其他国家的华人社区。
